Shelby Grebbin was Spectrum’s editorial assistant. Before joining Spectrum, she was staff assistant at the Nieman Foundation for Journalism. As a freelance journalist, she has covered stories related to public health, data transparency and prison health care. Shelby has a B.A. in journalism from Emerson College in Boston, Massachusetts.
Shelby Grebbin
Editorial Assistant
From this contributor
Researchers publish new dataset on minimally verbal autistic people
Researchers at the Massachusetts Institute of Technology published the first repository of vocalizations from minimally verbal autistic people. Those with few or no spoken words still produce a range of phonemes, or units of sound, that may serve as developmental markers or intervention targets.
Researchers publish new dataset on minimally verbal autistic people
By
Shelby Grebbin
18 May 2022 | 4 min read
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
Menopause poses significant challenges for autistic people, according to a small survey published in 2020 — the first to explore the transition among people with autism traits.
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
By
Shelby Grebbin
7 April 2022 | 5 min read
Web-based autism screening service raises a host of concerns
Neurona Health, a company in San Francisco, California, backed away from part of its newly launched services after Spectrum started reporting about them.
Web-based autism screening service raises a host of concerns
By
Shelby Grebbin
21 March 2022 | 6 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read